Full name
"KWIATY POLSKIE MARKETING" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"KWIATY POLSKIE MARKETING" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. DŁUGOSZA 26 / 1/4, 93-083 ŁÓDŹ
TAX ID7272690560
Rate company:
"KWIATY POLSKIE MARKETING" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7272690560
KRS0000268264
Share capital50,000.00 zł
address
UL. DŁUGOSZA 26 / 1/4, 93-083 ŁÓDŹ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7272690560
REGON
100261393
KRS
0000268264
Legal form
limited liability company
Register Address
UL. DŁUGOSZA 26 / 1/4, 93-083 ŁÓDŹ
Date of registration in KRS
2006-11-22
Date of commencement of economic activity
2006-11-22
Act signature
RDF/655880/24/178
Pkd codes
21.20.Z - Manufacture of medicines and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical substances
46.46.Z - Wholesale of pharmaceutical goods
47.91.Z - Retail sale via mail order houses or via Internet
58 - Publishing activities
63.99.Z - Other information service activities not elsewhere classified
68.10.Z - Buying and selling of own real estate
73.1 - Advertising
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL60 1140 1108 0000 3579 8800 1001 
PL90 1020 3352 0000 1102 0186 9643 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,1 | 0,3 | 0,7 | 98,9 |
EBITDA | 0 | 0,2 | 0,4 | 73,1 |
Short time liabilities | 1 | 0,7 | 0,1 | -78,3 |
Equity capital | 1,3 | 1,6 | 2,3 | 40,6 |
Operating profit (EBIT) | 0 | 0,2 | 0,4 | 71,8 |
Assets | 2,3 | 2,3 | 2,5 | 5,5 |
Net profit (loss) | 0,1 | 0,3 | 0,6 | 83,9 |
Cash | 0 | 0 | 0 | -73,6 |
Liabilities and provisions for liabilities | 1 | 0,7 | 0,1 | -78,3 |
Net income from sale | 0,4 | 0,5 | 0,8 | 60 |
Working assets | 0,1 | 0,1 | 0,2 | 70,4 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 9,5 | 20,7 | 27,1 | 6,4 |
Equity capital to total assets | 57 | 70,4 | 93,9 | 23,5 |
Gross profit margin | 37,9 | 64,6 | 80,3 | 15,7 |
EBITDA Margin | 11,8 | 42,2 | 45,6 | 3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 953 | 477 | 65 | -412 |
Financial statements
01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
TBK MEDICAL PARTNER
ŻYWIEC
Marek Mazurkiewicz
Zabrze
CMS Polska sp. z o.o.
Rzeszów
Katarzyna Poleszak
Toruń
Bioevolution sp. z o.o. sp.k.
Warszawa
DKR Medical sp. z o.o.
Poznań
"FARMEDICA" sp. z o.o.
Warszawa
Gama Sp. z o.o.
Ruda Śląska